申请人:SANDOZ LTD.
公开号:EP0490823A1
公开(公告)日:1992-06-17
6,7-Di(C₁₋₄alkoxy)-1-[3,5-di(C₁₋₄alkoxy)phenyl]-3,4-dihydro-3-hydroxy-methyl-isoquinolines, their physiologically-hydrolysable and -acceptable esters and acid addition salts thereof are novel. The said compounds and esters and pharmaceutically acceptable acid addition salts thereof are useful as pharmaceuticals, e.g. in the treatment of asthma.
6,7-二(C₁₋₄烷氧基)-1-[3,5-二(C₁₋₄烷氧基)苯基]-3,4-二氢-3-羟基-甲基-异喹啉、它们的生理上可水解和可接受的酯及其酸加成盐是新颖的。上述化合物和酯及其药学上可接受的酸加成盐可用作药物,例如用于治疗哮喘。